ABG
SANA icon

Ally Bridge Group’s Sana Biotechnology SANA Stock Holding History

Ally Bridge Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,015,273
Closed -$4.01M – 38
2022
Q4 		$4.01M Buy
1,015,273
+280,023
+38% +$1.37M 3.9% 12
2022
Q3 		$4.41M Buy
+735,250
New +$5.31M 2.91% 15

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Ally Bridge Group's SANA Position: Q1 2023 in Review

Ally Bridge Group sold out of Sana Biotechnology (SANA) in Q1 2023, closing a stake of 1,015,273 shares — an estimated $4.01M sold.

Ally Bridge Group first reported a position in SANA in Q3 2022 and held it in 2 quarters. The position peaked at $4.41M in Q3 2022. 120 funds tracked by Wall St. Rank hold SANA as of Q1 2023.

  • Ally Bridge Group reported no remaining Sana Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Ally Bridge Group sold 1,015,273 Sana Biotechnology shares in Q1 2023, an estimated $4.01M.
  • Ally Bridge Group first reported a position in Sana Biotechnology in Q3 2022 and held it in 2 quarters.
  • Ally Bridge Group's Sana Biotechnology position peaked at $4.41M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2023.

Based on Ally Bridge Group's 13F filing for Q1 2023, filed 15 May 2023.